| 317 | 0 | 31 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 了解徐州市贾汪区人民医院糖尿病患者降糖及护肾药物使用情况,分析临床药师药学服务情况与效果,以促进医院药学服务发展。方法 收集2022年1月—2024年7月徐州市贾汪区人民医院收治的411例糖尿病肾病患者的临床信息和药学服务记录,统计分析患者的临床基础信息和生化指标,深入探究患者的药物使用情况及药学服务成效。结果 从收集的123例门诊患者及288例住院患者临床信息可知,患者疾病主要以2型糖尿病肾病Ⅴ期为主;降糖药主要分为口服降糖药、胰岛素及其类似物;护肾药主要分为非甾体醛固酮受体拮抗剂与中成药制剂;药学服务内容主要为联合使用合理性,其次为药物重整。结论 临床药师的药学服务在糖尿病肾病患者的治疗过程中发挥着重要作用,能够保障用药合理性,并提升药师价值。
Abstract:Objective To investigate the use of hypoglycemic and nephroprotective medications among diabetic patients at Jiawang District People's Hospital in Xuzhou City, and to analyze the provision and outcomes of clinical pharmacist services to promote the development of hospital pharmacy services. Methods Clinical information and pharmaceutical service records of 411 diabetic nephropathy patients admitted to Jiawang District People's Hospital, Xuzhou City, from January 2022 to July 2024 were collected. Statistical analysis was conducted on patients' clinical baseline information and biochemical indicators to investigate medication usage patterns and the effectiveness of pharmaceutical services. Results Clinical data from 123 outpatients and 288 inpatients revealed that most patients had stage Ⅴ type 2 diabetic nephropathy. Antidiabetic drugs were primarily categorized as oral hypoglycemic agents, insulin and its analogues; Nephroprotective agents were primarily nonsteroidal aldosterone receptor antagonists and traditional Chinese medicine formulations. Pharmaceutical services primarily focused on rational combination therapy, followed by medication reconciliation. Conclusion Pharmacist-provided pharmaceutical services play a crucial role in the treatment of diabetic nephropathy patients, ensuring rational medication use and enhancing the value of pharmacists.
[1]马永超,方玉,周璇,等.2型糖尿病合并贫血患者的临床特点分析[J].医药前沿,2024,14(32):13-15.
[2]肖丽涵,黄汉兴.2型糖尿病合并糖尿病肾病的临床病理特征及预后分析[J].糖尿病新世界,2024,27(16):36-38.
[3]Sagoo M K, Gnudi L. Diabetic nephropathy:An overview[J]. Methods Mol Biol, 2020,2067:3-7.
[4]毕宇芳.2型糖尿病合并慢性肾脏病患者口服降糖药治疗中国专家共识(2019年更新版)解读[J].内科理论与实践,2019,14(6):333-336.
[5]《慢性肾脏病3~5期非透析中西医结合诊疗专家共识》编写组.慢性肾脏病3~5期非透析中西医结合诊疗专家共识[J].中国中西医结合杂志,2022,42(7):791-801.
[6]都丽萍,李春英,王睿韬,等.2型糖尿病患者降糖药物治疗现状及药学服务需求调查[J].临床药物治疗杂志,2022,20(1):57-62.
[7]蒋元霜,张珂承,李若璞,等.血糖管理指标与2型糖尿病慢性并发症的研究进展[J].临床与病理杂志,2024,44(8):1126-1131.
[8]刘露,朱佳蕾,张芸婷,等.临床药师通过不同切入点参与肾移植受者围妊娠期药学服务的案例分析[J].中南药学,2025,23(1):262-265.
[9]张丙魏,严茜茜,杨营营,等.临床药师在精神科开展药学服务模式的实践效果分析[J].中医药管理杂志,2024,32(23):71-74.
[10]李利华,刘华清.药学服务干预对于2型糖尿病性肾病患者的应用效果及安全性[J].中国当代医药,2024,31(18):94-97.
基本信息:
DOI:10.20256/j.cnki.zgdxbl.20251215.016
中图分类号:R692.9;R587.2
引用信息:
[1]张晓玙.糖尿病肾病患者降糖药物与肾保护药物应用现状及药学服务模式研究[J].中国典型病例大全,2026,20(01):606-612.DOI:10.20256/j.cnki.zgdxbl.20251215.016.
2025-12-15
2025-12-15
2025-12-15